NCT05134311
Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies
Recruiting
NAAges 18+InterventionalTreatmentNorthwell HealthInvestigator-initiated
~270 participants
Updated 2026-06-15 on ClinicalTrials.gov
What's tested:PIUR tUS Imaging System
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
30 Day re-admission
Measured over 30 Days after imaging
Conditions
Where it's being run
1 sites across 1 statesNew York1
Study leadership
- Alisha Oropallo, MD · PRINCIPAL_INVESTIGATOR · Northwell Health Comprehensive Wound Healing & Hyperbaric Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age 18 years of age or older
Suspected vascular insufficiency that requires ultrasound evaluation
Subject is able to sign a consent form
Scheduled ultrasound testing at the wound center to evaluate vasculature
Exclusion
Younger than 18 years old
Subject is not scheduled to have ultrasound testing at the wound center
Subject is unable to or refuses to consent to participate
What this trial measures
- 30 Day re-admission30 Days after imaging
The primary endpoint of the study will be the treatment outcomes for the patients. We will review readmission rates (30 days from the day of the ultrasound) as well as compliance to first follow-up appointment after the ultrasound of interventional cohort. These endpoints will be compared to those of a historical cohort of persons who were treated for similar pathologies in the past.